Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

Craig E. Daniels, Mark C. Wilkes, Maryanne Edens, Ted J. Kottom, Stephen J. Murphy, Andrew H. Limper, Edward B. Leof

Research output: Contribution to journalArticlepeer-review

492 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences